tiprankstipranks
Trending News
More News >
Lyell Immunopharma (LYEL)
NASDAQ:LYEL
US Market
Advertisement

Lyell Immunopharma (LYEL) Revenue

Compare
143 Followers

Lyell Immunopharma Revenue

Lyell Immunopharma had a revenue of 7.00K in the quarter ending Mar 31, 2025, with -36.36%. This bring the company's revenue in the last twelve months to 65.00K, Decreased 6.56%. In the fiscal year ending Dec 31, 2024, Lyell Immunopharma had annual revenue of 61.00K with -53.08% growth.
Revenue (ttm)
65.00K
Revenue Growth
-4.41%
P/S Ratio
2366.86
Revenue/Employee
$203
Employees
300
Market Cap
$144.38M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
61.00K-69.00K-53.08%
Dec 31, 2023
130.00K-84.55M-99.85%
Dec 31, 2022
84.68M74.03M+695.15%
Dec 31, 2021
10.65M2.89M+37.31%
Dec 31, 2020
7.76M7.10M+1,080.52%
Dec 31, 2019
657.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis